Mundipharma fined for misleading advertising of opioids The international affiliate of Purdue Pharma was issued 24 infringement notices by the Therapeutic Goods Administration.
New patient guide aims to reduce opioid harms A lack of information regarding opioid use after hospital discharge can be dangerous for some patients, but a new guide aims to close that gap.
Advocates hail ‘game changing’ PBS listing of buprenorphine Harm-reduction advocates have long called for an end to the surprisingly high cost of opioid substitution therapy.
National flu death toll tops 250 Australia is battling through one of its deadliest flu seasons on record.
Hospital to introduce opioid plan to tackle risk of post-surgery dependence A Perth hospital will move to introduce opioid-weaning plans for post-surgery patients in a bid to address rising rates of opioid dependency.
Flu death toll rises Australia’s horror early flu season has continued, with the confirmed number of influenza-related mortalities now at 79.
Renewed calls to fully subsidise methadone treatment GPs and addiction experts fear hidden costs are preventing more people from accessing treatment.
Naloxone: What should GPs know? newsGP speaks with an addiction medicine expert about the ‘EpiPen of overdose’.
Should GPs be able to prescribe buprenorphine without restriction? As Australia battles a spike in opioid-related deaths, research suggests advantages in much greater availability of pharmacotherapy treatment.
New report exposes severity of harm caused by opioid use The AIHW has shed light on the global issue of harm from opioid use, focusing on comparisons between Australia and Canada.